Testing and research into HIV/AIDS took a major step forward in June 2007 with the inauguration of a $5 million HIV/AIDS Bio-containment Laboratory whose development was spearheaded by research pioneer Dr. Mark Wainberg.
Although there is little scientific evidence that behaviour can be changed with the help of neurofeedback, some benefits may still result from the technique’s placebo effects.
A two-year study at the JGH has determined that thyroid cancer patients really need and benefit from the support of a nurse navigator.
A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.
The rate of C. difficile infection among hospitalized patients drops dramatically when all patients are tested for the bacteria before being admitted to hospital, says a clinical study headed by a JGH physician and researcher.
Youths at risk were the focus of discussions among healthcare professionals in the mental health field at the JGH Department of Psychiatry’s 11th annual Research Day in April.